These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18381458)

  • 1. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
    Wang SS; Smiraglia DJ; Wu YZ; Ghosh S; Rader JS; Cho KR; Bonfiglio TA; Nayar R; Plass C; Sherman ME
    Cancer Res; 2008 Apr; 68(7):2489-97. PubMed ID: 18381458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
    Costello JF; Hong C; Plass C; Smiraglia DJ
    Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
    Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
    Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
    Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
    Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.
    Dai Z; Weichenhan D; Wu YZ; Hall JL; Rush LJ; Smith LT; Raval A; Yu L; Kroll D; Muehlisch J; Frühwald MC; de Jong P; Catanese J; Davuluri RV; Smiraglia DJ; Plass C
    Genome Res; 2002 Oct; 12(10):1591-8. PubMed ID: 12368252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.
    Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY
    Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
    Costello JF; Frühwald MC; Smiraglia DJ; Rush LJ; Robertson GP; Gao X; Wright FA; Feramisco JD; Peltomäki P; Lang JC; Schuller DE; Yu L; Bloomfield CD; Caligiuri MA; Yates A; Nishikawa R; Su Huang H; Petrelli NJ; Zhang X; O'Dorisio MS; Held WA; Cavenee WK; Plass C
    Nat Genet; 2000 Feb; 24(2):132-8. PubMed ID: 10655057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction landmark genome scanning.
    Costello JF; Smiraglia DJ; Plass C
    Methods; 2002 Jun; 27(2):144-9. PubMed ID: 12095273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
    Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
    Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma.
    Wimmer K; Zhu Xx XX; Rouillard JM; Ambros PF; Lamb BJ; Kuick R; Eckart M; Weinhäusl A; Fonatsch C; Hanash SM
    Genes Chromosomes Cancer; 2002 Mar; 33(3):285-94. PubMed ID: 11807986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.
    Sova P; Feng Q; Geiss G; Wood T; Strauss R; Rudolf V; Lieber A; Kiviat N
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):114-23. PubMed ID: 16434596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity.
    Sakamoto H; Suzuki M; Abe T; Hosoyama T; Himeno E; Tanaka S; Greally JM; Hattori N; Yagi S; Shiota K
    Genes Cells; 2007 Oct; 12(10):1123-32. PubMed ID: 17903172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
    Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
    Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
    Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.
    Park J; Brena RM; Gruidl M; Zhou J; Huang T; Plass C; Tockman MS
    Cancer Biomark; 2005; 1(2-3):193-200. PubMed ID: 17192040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of CpG island methylation biomarkers using restriction landmark genomic scanning.
    Smiraglia DJ; Plass C
    Ann N Y Acad Sci; 2003 Mar; 983():110-9. PubMed ID: 12724216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
    Smiraglia DJ; Plass C
    Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
    Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
    Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse.
    Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K
    Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.